Literature DB >> 19624255

Synthesis and biological evaluation of new 4-thiazolidinone derivatives.

Ozlen Güzel1, Aydin Salman.   

Abstract

A series of new 2-aryl-4-thiazolidinones (3 and 4) was synthesized from 2-hydroxy-2,2-diphenyl-N'-[(substituted phenyl)methylene]acetohydrazides (2) and mercaptoacetic acid or 2-mercaptopropionic acid. The antimycobacterial activity of these compounds was determined and several leads with 95-99% inhibition at 6.25 microg/mL test concentration were identified. In addition, antitumor activities were measured against several tumor cell lines, and significant growth inhibition was observed for compound 4p. Taken together, 2-aryl-4-thiazolidinones were shown to be promising scaffolds for both antimycobacterial and tumor-targeting compounds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624255     DOI: 10.1080/14756360802608021

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  4 in total

1.  Synthesis, antimicrobial and antiviral testing of some new 1-adamantyl analogues.

Authors:  Ghada S Hassan; Ali A El-Emam; Laila M Gad; Alaa Eldin M Barghash
Journal:  Saudi Pharm J       Date:  2010-05-31       Impact factor: 4.330

2.  N-[5-Methyl-2-(2-nitro-phen-yl)-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide monohydrate.

Authors:  Mehmet Akkurt; Ismail Celik; Hale Demir; Sumru Ozkırımlı; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-08

Review 3.  The Role of Ionic Liquids in the Pharmaceutical Field: An Overview of Relevant Applications.

Authors:  Sónia N Pedro; Carmen S R Freire; Armando J D Silvestre; Mara G Freire
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

4.  Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors.

Authors:  Özlen Güzel-Akdemir; Andrea Angeli; Kübra Demir; Claudiu T Supuran; Atilla Akdemir
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.